Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

Canada Generic Drug Market Trends, Share, Size, Growth, Opportunity, and Forecast 2023

Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion-dollar industry in Canada.

The report entitled “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Key Questions Answered in This Report:

What are generic drugs? How are they different from branded drugs?
How has the Canadian generic drug market performed in recent years?
How have generics performed compared to branded drugs?
What were the total sales and prescriptions for generic drugs in Canada?
Who are the key players in the Canadian generic drug market? How have they performed?
What is the structure of the generic drug market in Canada?
What is the pricing mechanism of generic drugs in Canada?
What is the value chain of generic drugs in Canada?
What are the regulations for generic drugs in Canada?
How are generic drugs distributed in Canada?
How are generic drugs manufactured?
What are the raw material and machinery requirements to manufacture generic drugs?
What are the drivers and challenges in the generic drug market in Canada?

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Canada Generic Drug Market: Introduction
4.1 What are Generics?
4.2 Unbranded and Branded Generics
4.3 Authorized Generics
4.4 Specialty Generics
5 Why is the Generic Drug Market So Lucrative in Canada
5.1 Blockbuster Drugs Facing Patent Expiration
5.2 Substantial Price Difference Between Branded and Generic Drugs
5.3 Government Incentives
5.4 Savings for Drug Purchasers
5.5 Biosimilars
5.6 Ageing Population and Increasing Prevalence of Life Style Diseases
6 Global Generic Drug Market
6.1 Generic Drug Market Performance
6.1.1 Value Trend
6.1.2 Volume Trend
6.2 Market Breakup by Country
6.3 Most Prescribed Generic and Branded Drugs
6.4 Market Forecast
7 Canada Generic Drug Market
7.1 Canada Pharmaceutical Market Performance
7.1.1 Value Trends
7.1.2 Volume Trends
7.1.3 Market by Type
7.1.4 Market Forecast
7.2 Canada Generic Drug Market Performance
7.2.1 Value Trends
7.2.2 Volume Trends
7.2.3 Market Forecast
8 SWOT Analysis
8.1 Strengths
8.2 Weaknesses
8.3 Opportunities
8.4 Threats
9 Value Chain Analysis
9.1 Research and Development
9.2 Manufacturing
9.3 Marketing
9.4 Distribution
10 Pricing Mechanism and Profit Margins at Various Levels of Supply Chain
11 Porter’s Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Canada Generic Drug Market: Competitive Landscape
12.1 Canada Generic Drug Market – Competitive Structure
12.2 Canada Generic Drug Market – Sales Breakup of Key Players
12.3 Canada Generics Distribution – Breakup by Channel
12.4 Canada Generic Drug Market – Average Retail Price Per Prescription (Generic vs. Branded)
13 Canada Generic Drug Market: Key Success Factors
14 Canada Generic Drug Market: Road Blocks
15 Canada Generic Drug Market: Regulatory Framework
15.1 Overview of Pharmaceutical Regulations
15.2 Pre-Market Drug Submission Requirements for Generic Drugs
15.3 Review Process for Generic Drugs
15.4 Generic Drug Approval and Declaration of Its Bioequivalence
15.5 Other Important Consideration
16 Generic Drug Manufacturing Process
16.1 Manufacturing Process
16.2 Raw Material Requirements
16.3 Raw Materials Pictures
16.4 Land and Construction Requirements
16.5 Machinery and Infrastructure Requirements
16.6 Machinery Pictures
16.7 Plant Layout
16.8 Packaging Requirements
16.9 Utility Requirements
16.10 Manpower Requirements
17 Canada Generic Drug Market - Key Company Profiles


List Of Tables

Table 1: Canada: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: Global: Generic Drug Market: Sales Volume and Growth of Major Markets, 2017
Table 3: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2017
Table 4: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2017
Table 5: Canada: Distribution of Generic Drugs: Breakup by Channel (in %), 2017
Table 6: Generic Drug Manufacturing Plant: Raw Material Requirements
Table 7: Generic Drug Manufacturing Plant: Land and Construction Requirements
Table 8: Generic Drug Manufacturing Plant: Machinery Requirements
Table 9: Generic Drug Manufacturing Plant: Utility Requirements
Table 10: Generic Drug Manufacturing Plant: Manpower Requirements


List Of Figures

Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: Canada: Patent Expiry Exposure (in Billion US$)
Figure 4: Canada: Savings from Generic Drugs (in Billion US$), 2010-2017
Figure 5: Global: Generic Drug Market: Sales Value (in Billion US$), 2010-2017
Figure 6: Global: Generic Drug Market: Sales Volume (in Billion Units), 2010-2017
Figure 7: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2017
Figure 8: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2017
Figure 9: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 10: Global: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2018-2023
Figure 11: Global: Generic Drug Industry: SWOT Analysis
Figure 12: Global: Generic Drug Industry: Value Chain Analysis
Figure 13: Pricing Trends and Profit Margins at Various Levels of Supply Chain
Figure 14: Global: Generic Drug Industry: Porter’s Five Forces Analysis
Figure 15: Canada: Pharmaceutical Market: Sales Value (in Billion US$), 2011-2017
Figure 16: Canada: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 17: Canada: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2010-2017
Figure 18: Canada: Pharmaceutical Market Forecast: Sales Volume (in Million Prescriptions), 2018-2023
Figure 19: Canada: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2010 and 2017
Figure 20: Canada: Pharmaceutical Market Forecast: Sales Value Breakup of Branded and Generic Drugs (in %), 2010 and 2017
Figure 21: Canada: Generic Drug Market: Sales Value (in Billion US$), 2010-2017
Figure 22: Canada: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 23: Canada: Generic Drug Market: Sales Volume (in Million Prescriptions), 2010-2017
Figure 24: Canada: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2018-2023
Figure 25: Canada: Generic Drug Market: Sales Breakup of Key Players (in %), 2017
Figure 26: Canada: Generic Drug Market: Average Retail Price Per Prescription (Generics vs. Branded- in US$ Per Prescription), 2010-2017
Figure 27: Canada: Generic Drug Market: Regulatory Framework for Generic Drugs
Figure 28: Generic Drug Manufacturing Plant: Detailed Process Flow
Figure 29: Generic Drug Manufacturing Plant: Plant Layout
Figure 30: Generic Drug Manufacturing Plant: Packaging Requirements


Paediatric Consumer Health in Canada

Demographic trends continue to undermine the growth potential of paediatric consumer health in Canada. The 0-14-year-old population continues to experience slow growth, accounting for a relatively small share of the

USD 990 View Report

Dietary Supplements in Canada

Dietary supplements is a relatively mature category, with many supplements experiencing value decline in 2018. Herbal/traditional dietary supplements witnessed contradicting growth rates as consumers shifted their preferences. Evening primrose oil

USD 990 View Report

2019 Generic Drug Competitive Intelligence: Sun Pharma Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization

USD 950 View Report

Global Markets for Generic Drugs

Report Scope:This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed

USD 4125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available